Spots Global Cancer Trial Database for The Prevalence and Characteristics of Adrenal Incidentaloma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Prevalence and Characteristics of Adrenal Incidentaloma

Official Title: The Prevalence and Characteristics of Adrenal Incidentaloma: A Prospective Study

Study ID: NCT04682938

Conditions

Prevalence

Adrenal Incidentaloma

Interventions

Study Description

Brief Summary: To investige the prevalence, characteristics and prognosis of adrenal incidentalomas in Chinese adults.

Detailed Description: With the development of imaging detection technology and its wide application in clinic, the detection rate of adrenal incidentaloma (AI) has been greatly improved. Most AI are benign and do not have the function of autonomic hormone secretion, but about 20% of them have function and can secrete adrenal hormone autonomously. Studies based on biopsy reports show that the prevalence of AI is about 2%, and the prevalence of AI detected by CT scan is 1% - 4.5%. However, most of these studies are retrospective, and there may be selection bias and other confounding factors. There is no large sample prospective study on the prevalence of AI in the general population. The purpose of this study is to prospectively include patients with adrenal incidentaloma in community physical examination population, and evaluate their function and prognosis. The research results will provide new evidence for standardized diagnosis and treatment of adrenal incidentaloma in the future.